Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaboration
- Author
- BAMIAS, A1 ; TZANNIS, K1 ; STRAVODIMOS, K9 ; CHRISOFOS, M10 ; FOUNTZILAS, G6 ; ELAIDI, R.-T4 ; DIMOPOULOS, M. A1 ; BAMIA, C11 ; BEUSELINCK, B2 3 ; OUDARD, S4 ; ESCUDIER, B5 ; DIOSYNOPOULOS, D6 ; PAPAZISIS, K7 ; LANG, H8 ; WOLTER, P2 ; DE GUILLEBON, E4
[1] Department of Clinical Therapeutics, University of Athens, Athens, Greece
[2] Department of General Medical Oncology and Laboratory for Experimental Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium
[3] Inserm U674 Génomique fonctionnelle des tumeurs solides, Université Paris-5 René Descartes, Paris, France
[4] Hopital Europeen Georges Pompidou, Paris, France
[5] Institute Gustav Roussy, Villejuif, France
[6] Department of Medical Oncology, Papageorgiou Hospital, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece
[7] Theagenion Hospital, Thessaloniki, Greece
[8] Centre Hospitalier Regional Universitaire, Strasbourg, France
[9] First Department of Urology, University of Athens, Athens, Greece
[10] Second Department of Urology, University of Athens, Athens, Greece
[11] Department of Hygiene, Epidemiology and Medical Statistics, University of Athens, Athens, Greece - Source
British journal of cancer. 2013, Vol 109, Num 2, pp 332-341, 10 p ; ref : 1 p
- CODEN
- BJCAAI
- ISSN
- 0007-0920
- Scientific domain
- Medical oncology
- Publisher
- Nature Publishing Group, Basingstoke
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Author keyword
- prognostic model renal cancer sunitinib targeted therapy
- Keyword (fr)
- Antiangiogénique Anticancéreux Cancer rein Cancérologie Carcinome Homme Hypernéphrome Modèle Médicament ciblé Métastase Pronostic Stade avancé Sunitinib Thérapeutique ciblée Traitement Validation Europe Cancer Enzyme Inhibiteur de la tyrosine kinase Inhibiteur enzyme Inhibiteur multikinase Pathologie de l'appareil urinaire Pathologie du rein Protein-tyrosine kinase Transferases Tumeur maligne
- Keyword (en)
- Antiangiogenic agent Antineoplastic agent Kidney cancer Cancerology Carcinoma Human Grawitz tumor Models Targeted drug Metastasis Prognosis Advanced stage Sunitinib Targeted therapy Treatment Validation Europe Cancer Enzyme Tyrosine kinase inhibitor Enzyme inhibitor Multikinase inhibitor Urinary system disease Kidney disease Protein-tyrosine kinase Transferases Malignant tumor
- Keyword (es)
- Antiangiogenico Anticanceroso Cáncer del riñón Cancerología Carcinoma Hombre Hipernefroma Modelo Medicamento dirigido Metástasis Pronóstico Estadio avanzado Sunitinib Terapéutica dirigida Tratamiento Validación Europa Cáncer Enzima Inhibidor tyrosine kinase Inhibidor enzima inhibidor multicinasa Aparato urinario patología Riñón patología Protein-tyrosine kinase Transferases Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B04 Tumors / 002B04C Multiple tumors. Solid tumors. Tumors in childhood (general aspects)
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B14 Nephrology. Urinary tract diseases / 002B14D Tumors of the urinary system / 002B14D01 Kidneys
- Discipline
- Nephrology. Urinary tract diseases Tumours
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 27583933
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1038/bjc.2013.341 
https://dx.doi.org/10.1038/bjc.2013.341
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1038\/bjc.2013.341\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:146:\"Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaboration\";s:9:\"\u0000*\u0000jtitle\";s:25:\"British journal of cancer\";s:9:\"\u0000*\u0000stitle\";s:13:\"Br. j. cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:3:\"109\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"332\";s:8:\"\u0000*\u0000epage\";s:3:\"341\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0007-0920\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"BAMIAS\";s:10:\"\u0000*\u0000aufirst\";s:1:\"A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:10:\"TZANNIS, K\";i:1;s:14:\"STRAVODIMOS, K\";i:2;s:12:\"CHRISOFOS, M\";i:3;s:13:\"FOUNTZILAS, G\";i:4;s:12:\"ELAIDI, R.-T\";i:5;s:16:\"DIMOPOULOS, M. A\";i:6;s:8:\"BAMIA, C\";i:7;s:13:\"BEUSELINCK, B\";i:8;s:9:\"OUDARD, S\";i:9;s:11:\"ESCUDIER, B\";i:10;s:16:\"DIOSYNOPOULOS, D\";i:11;s:12:\"PAPAZISIS, K\";i:12;s:7:\"LANG, H\";i:13;s:9:\"WOLTER, P\";i:14;s:15:\"DE GUILLEBON, E\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BJCAAI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:146:\"Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaboration\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1038\/bjc.2013.341\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:146:\"Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaboration\";s:9:\"\u0000*\u0000jtitle\";s:25:\"British journal of cancer\";s:9:\"\u0000*\u0000stitle\";s:13:\"Br. j. cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:3:\"109\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"332\";s:8:\"\u0000*\u0000epage\";s:3:\"341\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0007-0920\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"BAMIAS\";s:10:\"\u0000*\u0000aufirst\";s:1:\"A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:10:\"TZANNIS, K\";i:1;s:14:\"STRAVODIMOS, K\";i:2;s:12:\"CHRISOFOS, M\";i:3;s:13:\"FOUNTZILAS, G\";i:4;s:12:\"ELAIDI, R.-T\";i:5;s:16:\"DIMOPOULOS, M. A\";i:6;s:8:\"BAMIA, C\";i:7;s:13:\"BEUSELINCK, B\";i:8;s:9:\"OUDARD, S\";i:9;s:11:\"ESCUDIER, B\";i:10;s:16:\"DIOSYNOPOULOS, D\";i:11;s:12:\"PAPAZISIS, K\";i:12;s:7:\"LANG, H\";i:13;s:9:\"WOLTER, P\";i:14;s:15:\"DE GUILLEBON, E\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BJCAAI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:146:\"Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaboration\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:20:\"10.1038\/bjc.2013.341\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1038\/bjc.2013.341\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:146:\"Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaboration\";s:9:\"\u0000*\u0000jtitle\";s:25:\"British journal of cancer\";s:9:\"\u0000*\u0000stitle\";s:13:\"Br. j. cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:3:\"109\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"332\";s:8:\"\u0000*\u0000epage\";s:3:\"341\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0007-0920\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"BAMIAS\";s:10:\"\u0000*\u0000aufirst\";s:1:\"A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:10:\"TZANNIS, K\";i:1;s:14:\"STRAVODIMOS, K\";i:2;s:12:\"CHRISOFOS, M\";i:3;s:13:\"FOUNTZILAS, G\";i:4;s:12:\"ELAIDI, R.-T\";i:5;s:16:\"DIMOPOULOS, M. A\";i:6;s:8:\"BAMIA, C\";i:7;s:13:\"BEUSELINCK, B\";i:8;s:9:\"OUDARD, S\";i:9;s:11:\"ESCUDIER, B\";i:10;s:16:\"DIOSYNOPOULOS, D\";i:11;s:12:\"PAPAZISIS, K\";i:12;s:7:\"LANG, H\";i:13;s:9:\"WOLTER, P\";i:14;s:15:\"DE GUILLEBON, E\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BJCAAI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:146:\"Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaboration\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1038\/bjc.2013.341\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:146:\"Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaboration\";s:9:\"\u0000*\u0000jtitle\";s:25:\"British journal of cancer\";s:9:\"\u0000*\u0000stitle\";s:13:\"Br. j. cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:3:\"109\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"332\";s:8:\"\u0000*\u0000epage\";s:3:\"341\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0007-0920\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"BAMIAS\";s:10:\"\u0000*\u0000aufirst\";s:1:\"A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:10:\"TZANNIS, K\";i:1;s:14:\"STRAVODIMOS, K\";i:2;s:12:\"CHRISOFOS, M\";i:3;s:13:\"FOUNTZILAS, G\";i:4;s:12:\"ELAIDI, R.-T\";i:5;s:16:\"DIMOPOULOS, M. A\";i:6;s:8:\"BAMIA, C\";i:7;s:13:\"BEUSELINCK, B\";i:8;s:9:\"OUDARD, S\";i:9;s:11:\"ESCUDIER, B\";i:10;s:16:\"DIOSYNOPOULOS, D\";i:11;s:12:\"PAPAZISIS, K\";i:12;s:7:\"LANG, H\";i:13;s:9:\"WOLTER, P\";i:14;s:15:\"DE GUILLEBON, E\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BJCAAI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:146:\"Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaboration\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1038\/bjc.2013.341\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:146:\"Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaboration\";s:9:\"\u0000*\u0000jtitle\";s:25:\"British journal of cancer\";s:9:\"\u0000*\u0000stitle\";s:13:\"Br. j. cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:3:\"109\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"332\";s:8:\"\u0000*\u0000epage\";s:3:\"341\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0007-0920\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"BAMIAS\";s:10:\"\u0000*\u0000aufirst\";s:1:\"A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:10:\"TZANNIS, K\";i:1;s:14:\"STRAVODIMOS, K\";i:2;s:12:\"CHRISOFOS, M\";i:3;s:13:\"FOUNTZILAS, G\";i:4;s:12:\"ELAIDI, R.-T\";i:5;s:16:\"DIMOPOULOS, M. A\";i:6;s:8:\"BAMIA, C\";i:7;s:13:\"BEUSELINCK, B\";i:8;s:9:\"OUDARD, S\";i:9;s:11:\"ESCUDIER, B\";i:10;s:16:\"DIOSYNOPOULOS, D\";i:11;s:12:\"PAPAZISIS, K\";i:12;s:7:\"LANG, H\";i:13;s:9:\"WOLTER, P\";i:14;s:15:\"DE GUILLEBON, E\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BJCAAI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:146:\"Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaboration\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
